SRRK
Scholar Rock Holding Corporation
12.08
USD
This page is just a preview of the data found in TrendSpider’s full version
Scholar Rock Holding Corporation stock is up 2.72% since 30 days ago. The next earnings date is Mar 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 5 November’s closed higher than October. In the last 5 Unusual Options Trades, there were 5 CALLs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 01 Nov 16:30 | 19 Apr, 2024 | 10.00 | 123 | ||
| 09 Nov 17:23 | 19 Jan, 2024 | 7.50 | 645 | ||
| 09 Nov 18:00 | 19 Jan, 2024 | 7.50 | 645 | ||
| 16 Nov 20:07 | 19 Jan, 2024 | 7.50 | 639 | ||
| 17 Nov 16:28 | 19 Jan, 2024 | 12.50 | 210 |
Scholar Rock Holding Corporation focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin, and SRK-181, which is in Phase 1 clinical trials. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients.
